Hadassah

Placental Cells Found to Have Potential to Mitigate Acute Radiation Syndrome

Monday, Oct 24 2011

"In pre-clinical studies," notes Prof. Raphael Gorodetsky, head of the Biotechnology and Radiobiology Laboratory at the Sharrett Institute of Oncology at Hadassah University Medical Center, "we found that placental-derived cells potentially have the ability to increase the survival rate of animals following exposure to lethal doses of total body irradiation."

These placental (PLX) cells, developed by Pluristem Therapeutics Inc., treat life-threatening complications associated with Acute Radiation Syndrome (ARS).

During the studies, animals were injected intravenously with either PLX cells or a placebo, on the day after being exposed to lethal doses of radiation. Nine days following treatment with the PLX cells, the animals' bone marrow and spleen were examined for signs of hematopoietic (blood forming) tissue. On day 23, bone marrow and blood samples were examined in the surviving animals. Overall survival and body weight changes were also monitored. The researchers found in the animals treated with the PLX cells:

  • an up to four-fold increase in the survival rate accompanied by a corresponding weight regain
  • an increase in red-cell count on days 21-23
  • an elevated number of hematopoietic colonies on day 9

Over the next few months, Prof. Gorodetsky and his team will focus on better understanding the PLX cells' mechanism of action as an "off the shelf" post radiation treatment, which could potentially be used in the future for treating ARS patients.

"While our experiments using PLX cells in treating radiation exposure are ongoing and still evolving, these initial data are very encouraging," said Zami Aberman, Chairman and Chief Executive Officer of Pluristem. "PLX cells as a sole treatment may potentially enhance the survival of lethally irradiated individuals. Moreover, since our previous work indicated that PLX cells can enhance the engraftment of hematopoietic stem cells from cord blood, we can offer a multifaceted approach to reduce and treat the destruction of bone marrow that occurs following exposure to high-dose ionizing radiation. Stockpiled PLX cells can be administered acutely and as a bridging therapy to protect the bone marrow."

Comments

No comments yet.
First Name
Email
Comment
Enter this word:

Related Stories

alt_text

Friday, Mar 8 2019

Quick Action at Hadassah’s Milstein Heart Center Saves Exuberant Hasidic Dancer

“You can’t dance at all the weddings” is a common Hebrew and Yiddish expression. For Mr. Cohen (not his real name), a 49-year-old teacher, the wedding of a friend’s son was an occasion to get together with classmates from his post-high school yeshiva days when he was 19. Inclined to dance with joy at weddings, this twinkle-eyed, bearded Hassid increased the tempo in the presence of his long-ago pals.

READ MORE ›
alt_text

Friday, Mar 8 2019

Hadassah Surgeon Uses Revolutionary Surgery and Stem Cells to Restore Mobility

He grew up on the Mediterranean coast in Ashkelon, but Eyal Turgeman dreamed of becoming an African wilderness tour guide. After serving in the Israel Defense Forces’  elite paratroopers unit, he arrived in Namibia, a southwestern African country marked by rocky trails, sunshine, and sandy open spaces.

READ MORE ›
alt_text

Wednesday, Feb 27 2019

A Double Stroke at the Dead Sea

Imagine having a double stroke in two different arteries while on a day trip at the Dead Sea! What could be the chances of survival?

READ MORE ›
alt_text

Wednesday, Feb 27 2019

A Miracle in the Medical Intensive Care Unit at Hadassah —as recalled by Dr. Sigal Sviri, Director

On a cold December morning, a 26-year-old mother of two started developing flu symptoms, with fever, headache, and shortness of breath. As her breathing got worse, she came to the emergency room at Hadassah Hospital Ein Kerem and was admitted to the Medical Intensive Care Unit (MICU).

READ MORE ›

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Missions Department

missions@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Show More